ABBV
AbbVie Inc.$251.64-1.05% 1D· price as of Jun 30, 8:32 PM+34.72% over 1Y
Compare:ABBV
Mkt Cap
$444.6B
P/E
124.0×
Fwd P/E
15.4×
PEG
0.41
P/B
—
P/S
7.1×
EV/EBITDA
17.0×
Beta
0.31
Div Yield
2.7%
Payout
326.0%
ROE
—
Net Margin
5.8%
Short % Flt
1.3%
Inst. Own
76.9%
52-wk low $184.39$251.6452-wk high $255.99
+36.5% above low-1.7% from high
Seasonality — avg monthly return
Strongest Feb 7.0% · weakest Apr -5.3%Jan
-0.8
Feb
+7.0
Mar
+1.8
Apr
-5.3
May
-1.5
Jun
+4.0
Jul
+3.6
Aug
+2.6
Sep
+0.2
Oct
+1.5
Nov
+1.1
Dec
+4.8
Average month-over-month return per calendar month over the available history (~5 yrs); hover for the share of positive months. Past seasonality isn't predictive.
Ask AI about AbbVie Inc.
Gemini · web searchSearches the live web for current news & events plus this company's financials — and you can keep asking follow-up questions.
ABBV — recent news
Loading headlines…
Quality scorecard
vs Biotechnology · 8 peers · percentile rank
33 / 100
Below average
ROIC20.3%
71
ROE-129.2%
0
Gross margin70.2%
29
Operating margin32.8%
71
FCF yield4.0%
29
Net debt / EBITDA3.5×
0
Percentile vs 8 Biotechnology peers — higher = better (leverage inverted: less debt ranks higher). The faint tick is the peer median; the score is the average percentile. Annual fundamentals.